Symptoms, induced sputum eosinophil percentages and treatment with salmeterol or fluticasone in mild asthmatics

M. Tonelli, D. Giannini, A. Di Franco, S. Carnevali, M. L. Bartoli, S. Cianchetti, E. Bacci, F. L. Dente, L. Scuotri, B. Vagaggini, P. L. Paggiaro (Pisa, Italy)

Source: Annual Congress 2001 - Assessment and monitoring of inflammation in COPD and asthma
Session: Assessment and monitoring of inflammation in COPD and asthma
Session type: Poster Discussion
Number: 2231
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Tonelli, D. Giannini, A. Di Franco, S. Carnevali, M. L. Bartoli, S. Cianchetti, E. Bacci, F. L. Dente, L. Scuotri, B. Vagaggini, P. L. Paggiaro (Pisa, Italy). Symptoms, induced sputum eosinophil percentages and treatment with salmeterol or fluticasone in mild asthmatics. Eur Respir J 2001; 16: Suppl. 31, 2231

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of anti-inflammatory and clinical effects of beclomethasone dipropionate and salmeterol in moderate asthma
Source: Eur Respir J 2002; 20: 66-72
Year: 2002



Effect of salmeterol in asthmatic patients with low sputum eosinophils
Source: Eur Respir J 2001; 18: Suppl. 33, 336s
Year: 2001

Absence of sputum eosinophils in subjects with symptomatic asthma on inhaled budesonide
Source: Eur Respir J 2002; 20: Suppl. 38, 274s
Year: 2002

Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids
Source: Eur Respir J 2002; 20: 1364-1369
Year: 2002



Effect of the addition of montelukast to inhaled fluticasone propionate on immunopathology in bronchial biopsies from mild to moderate asthmatics
Source: Eur Respir J 2002; 20: Suppl. 38, 388s
Year: 2002

Comparison between fluticasone and salmeterol plus fluticasone on functional responses and sputum eosinophilia induced by allergen challenge
Source: Eur Respir J 2005; 26: Suppl. 49, 123s
Year: 2005

Combined treatment with fluticasone plus salmeterol protects against allergen induced asthmatic responses and subsequent increase in sputum eosinophils
Source: Eur Respir J 2002; 20: Suppl. 38, 189s
Year: 2002

Treatment with inhaled steroids in patients with symptoms suggestive of asthma but with normal lung function
Source: Eur Respir J 2008; 32: 989-996
Year: 2008



Airway hyperresponsiveness and treatment effectiveness during a one year study of the combination of salmeterol and fluticasone propionate (FP) compared with FP and salmeterol alone in mild to moderate asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 386s
Year: 2002

The effect of fluticasone vs fluticasone plus salmeterol on allergen-induced bronchial inflammation in asthmatic patients. A long-term RCT
Source: Eur Respir J 2004; 24: Suppl. 48, 125s
Year: 2004

Sustained reduction of bronchial hyperresponsiveness with inhaled fluticasone propionate in mild asthma within three days
Source: Eur Respir J 2002; 20: Suppl. 38, 197s
Year: 2002

Correlation between ECP in induced sputum and asthma symptoms in children treated with budesonide
Source: Eur Respir J 2001; 18: Suppl. 33, 450s
Year: 2001

The effects of treatment with fluticasone propionate alone and combination with salmeterol on asthma control and airway inflammation
Source: Eur Respir J 2003; 22: Suppl. 45, 287s
Year: 2003

Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma
Source: Eur Respir J 2005; 25: 41-46
Year: 2005



Effects of salmeterol, formoterol and placebo on pulmonary function and symptom recovery after histamine provocation in mild asthmatics
Source: Eur Respir J 2004; 24: Suppl. 48, 710s
Year: 2004

Influence of large and small dose of fluticasone propionate on clinical symptoms of bronchial asthma, lung function, bronchial hyperreactivity and eosinophilia in induced sputum
Source: Eur Respir J 2002; 20: Suppl. 38, 111s
Year: 2002

Low doses of inhaled fluticasone propionate induce sputum eosinophil apoptosis and inhibit IL-5 release in naive symptomatic asthmatics (FLIC19)
Source: Eur Respir J 2001; 18: Suppl. 33, 336s
Year: 2001

Effects of fluticasone and ciclesonide on pulmonary function and airway inflammation in stable mild asthmatics
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009


Eosinophil apoptosis in induced sputum (IS) from patients with mild symptomatic asthma during treatment with Fluticasone propionate (FP)
Source: Eur Respir J 2001; 18: Suppl. 33, 337s
Year: 2001

Dissociation in effects of fluticasone but not fluticasone/salmeterol on lung function and airway hyperresponsiveness in mild persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 385s
Year: 2002